NO953270L - Fibrinogenreceptorantagonister - Google Patents

Fibrinogenreceptorantagonister

Info

Publication number
NO953270L
NO953270L NO953270A NO953270A NO953270L NO 953270 L NO953270 L NO 953270L NO 953270 A NO953270 A NO 953270A NO 953270 A NO953270 A NO 953270A NO 953270 L NO953270 L NO 953270L
Authority
NO
Norway
Prior art keywords
fibrinogenreceptorantagonister
compounds
abncn
formula
receptor antagonist
Prior art date
Application number
NO953270A
Other languages
English (en)
Other versions
NO953270D0 (no
Inventor
David Alan Claremon
John J Baldwin
Nigel Liverton
Ben Askew
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO953270D0 publication Critical patent/NO953270D0/no
Publication of NO953270L publication Critical patent/NO953270L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A61K38/166—Streptokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Forbindelser ifølge oppfin- nelsen har formel (l) eller (2) O R2 R6 Q-(CH2)n-a-AB¿C-N-RS-C-R" m i- !,- O R2 R6 II l l Q-(CH2)n-a-AB¿C-Rs-c-R8 (2) R1 for eksempel (3). <w> (3) Forbindelsene har fibrinogenreseptor- antagonistaktivitet.
NO953270A 1993-02-22 1995-08-21 Fibrinogenreceptorantagonister NO953270L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2051793A 1993-02-22 1993-02-22
PCT/US1994/001881 WO1994018981A1 (en) 1993-02-22 1994-02-22 Fibrinogen receptor antagonists

Publications (2)

Publication Number Publication Date
NO953270D0 NO953270D0 (no) 1995-08-21
NO953270L true NO953270L (no) 1995-10-19

Family

ID=21799049

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953270A NO953270L (no) 1993-02-22 1995-08-21 Fibrinogenreceptorantagonister

Country Status (15)

Country Link
EP (1) EP0684823A4 (no)
JP (1) JP3173792B2 (no)
KR (1) KR960700722A (no)
CN (1) CN1118139A (no)
AU (1) AU680240B2 (no)
BG (1) BG99863A (no)
CA (1) CA2155123A1 (no)
CZ (1) CZ210895A3 (no)
FI (1) FI953916A (no)
HU (1) HUT71796A (no)
NO (1) NO953270L (no)
NZ (1) NZ262664A (no)
PL (1) PL310386A1 (no)
SK (1) SK102495A3 (no)
WO (1) WO1994018981A1 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849736A (en) * 1993-11-24 1998-12-15 The Dupont Merck Pharmaceutical Company Isoxazoline and isoxazole fibrinogen receptor antagonists
US5494921A (en) * 1994-09-16 1996-02-27 Merck & Co., Inc. Fibrinogen receptor antagonists
ZA963391B (en) * 1995-05-24 1997-10-29 Du Pont Merck Pharma Isoxazoline fibrinogen receptor antagonists.
NZ318926A (en) * 1995-08-30 1999-04-29 Searle & Co Alpha v beta 3 integrin (vitronectin) inhibitors or anatagonists derived from benzoic acid for treating diseases of cell adhesion
US6100423A (en) * 1995-08-30 2000-08-08 G. D. Searle & Co. Amino benzenepropanoic acid compounds and derivatives thereof
EP0854869B1 (en) 1995-09-29 2004-08-25 Eli Lilly And Company Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation
AU1345697A (en) * 1995-12-22 1997-07-17 Du Pont Merck Pharmaceutical Company, The Novel integrin receptor antagonists
AU2340997A (en) * 1996-03-27 1997-10-17 Merck & Co., Inc. A method for inhibiting clot formation
EA005526B1 (ru) * 1996-07-25 2005-04-28 Байоджен, Инк. Ингибиторы клеточной адгезии
US5900414A (en) * 1996-08-29 1999-05-04 Merck & Co., Inc. Methods for administering integrin receptor antagonists
DE19653647A1 (de) * 1996-12-20 1998-06-25 Hoechst Ag Vitronectin - Rezeptorantagonisten, deren Herstellung sowie deren Verwendung
CA2279927A1 (en) * 1997-02-06 1998-08-13 Merck & Co., Inc. Fibrinogen receptor antagonist prodrugs
AU6780398A (en) 1997-03-28 1998-10-22 Du Pont Merck Pharmaceutical Company, The Heterocyclic integrin inhibitor prodrugs
US6303625B1 (en) * 1998-07-27 2001-10-16 Ortho-Mcneil Pharmaceutical, Inc. Triazolopyridines for the treatment of thrombosis disorders
TR200200225T2 (tr) * 1999-07-28 2002-06-21 Avantis Pharmaceuticals Products Inc. İkameli okzo azahetrosiklil bileşikleri
CA2509565A1 (en) * 2002-12-20 2004-07-15 Pharmacia Corporation Mitogen activated protein kinase-activated protein kinase-2 inhibiting compounds
WO2008006540A1 (en) * 2006-07-12 2008-01-17 Syngenta Participations Ag Triazolopyridine derivatives as herbicides
AU2009244664A1 (en) * 2008-04-04 2009-11-12 Gilead Sciences, Inc. Triazolopyridinone derivatives for use as stearoyl CoA desaturase inhibitors
WO2010096722A1 (en) * 2009-02-20 2010-08-26 Takeda Pharmaceutical Company Limited 3-oxo-2, 3-dihydro- [1,2, 4] triazolo [4, 3-a]pyridines as soluble epoxide hydrolase (seh) inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5084466A (en) * 1989-01-31 1992-01-28 Hoffmann-La Roche Inc. Novel carboxamide pyridine compounds which have useful pharmaceutical utility
GB8913011D0 (en) * 1989-06-06 1989-07-26 Wellcome Found Anticonvulsant pyrazines
US5166154A (en) * 1989-10-17 1992-11-24 Boehringer Ingelheim Pharmaceuticals, Inc. Imidazo[1,2-a]piperazines
US5278161A (en) * 1990-06-28 1994-01-11 Hoffmann-La Roche Inc. Amino acid derivatives useful as renin inhibitors

Also Published As

Publication number Publication date
FI953916A0 (fi) 1995-08-21
AU6246594A (en) 1994-09-14
PL310386A1 (en) 1995-12-11
CN1118139A (zh) 1996-03-06
JP3173792B2 (ja) 2001-06-04
WO1994018981A1 (en) 1994-09-01
BG99863A (en) 1996-02-29
NZ262664A (en) 1997-04-24
KR960700722A (ko) 1996-02-24
HUT71796A (en) 1996-02-28
AU680240B2 (en) 1997-07-24
CA2155123A1 (en) 1994-09-01
FI953916A (fi) 1995-08-21
HU9502028D0 (en) 1995-09-28
EP0684823A4 (en) 1997-07-09
JPH08507072A (ja) 1996-07-30
CZ210895A3 (en) 1996-02-14
EP0684823A1 (en) 1995-12-06
SK102495A3 (en) 1997-01-08
NO953270D0 (no) 1995-08-21

Similar Documents

Publication Publication Date Title
NO953270L (no) Fibrinogenreceptorantagonister
ZA905150B (en) Substituted quinazolinones as angiotensin ii antagonists
TR200101155T2 (tr) 4-Aroil Piperidin CCR-3 Reseptör Antagonistleri III
PT618190E (pt) 9-¬glicil substituido)amido|-6-(substituido)-5-hidroxi-6-desoxitetraciclinas
TR200101961T2 (tr) 1,2-halkalı kinolin türevleri
EA200000098A1 (ru) 4-АМИНОПИРРОЛ(3,2-d)ПИРИМИДИНЫ В КАЧЕСТВЕ АНТАГОНИСТОВ РЕЦЕПТОРА НЕЙРОПЕПТИДА Y
ATE37375T1 (de) Phosphonyl-hydroxyacyl-aminosaeure-derivate und ihre verwendung als antihypertensiva.
DE68925155D1 (de) Verwendung von Halogenkohlenwasserstofflösungsmittel als Reinigungsmittel
MX9204661A (es) Compuestos intermedios derivados de eter y procedimiento para su preparacion.
ATE203670T1 (de) Verwendung von östrogenantagonisten und - agonisten zur hemmung pathologischer zustände
NO971538L (no) Purin- og guaninforbindelser som inhibitorer for PNP
ES2163638T3 (es) Nuevas n-(1-alquil-5-fenil-2,3,4,5-tetrahidro-1h-benzo(b)(1,5)diacepin-3-il)acetamidas.
FR2399430A1 (fr) Chlorhydrate dihydrate de 1-(4-amino-6, 7-dimethoxy-2-quinazolinyl)-4- (2-tetrahydrofuroyl)piperazine, et son utilisation comme agents antihypertensif
ATE195737T1 (de) Antagonisten des fibrinogenrezeptors
FI942457A (fi) Substituoitujen piperidiinien valmistus
DE69426452D1 (de) Fibrinogen receptor antagonisten
NO972887L (no) Piperidineddiksyrederivater anvendelige som fibrinogen-antagonistmiddel
SE8500107L (sv) Nya 8-alfa-acylaminoergoline
TR200001222T2 (tr) Yeni tetrasiklikler, bunların üretimi için işlem ve bu birleşikleri içeren farmasötik preparasyonlar.
FI955118A0 (fi) Herbisidiset substituoidut 1-fenyyli- tai 1-pyridinyyli-bentsotriatsolit
ES8701159A1 (es) Procedimiento para la obtencion de derivados de piperidina con actividad cardiovascular.
ES2062389T3 (es) Acidos glutaramicos sustituidos y sus derivados.
FI892222A0 (fi) Peptidalkoholer med antikoagulantverkan.
NO20002408D0 (no) 5-HT1F antagonister
DK365284A (da) 5-substituerede (1,2,4)triazolo(1,5-c)pyrimidin-2-aminer